- August 14, 2018India is rolling out a health-care plan for half a billion people. But are there enough doctors?
The Washington Post– August 14, 2018. The private sector expects huge profits when investing in health care, said Ramanan Laxminarayan, director at the Center for Disease Dynamics, Economics and Policy, and the government’s budget constraints simply won’t be able to match their expectations. “The private sector wants more money than the government wants to spend,” he […]
Read moreRead more Read More - August 7, 2018Just Rs 147 to help protect a kid from diseases in India.
Hindustan Times– August 7, 2018. “‘There’s been a four-fold increase in the immunization budget over the last four years, yet no proper economic costing study has been done. This study is significant because with the addition of more life-saving vaccines, as it should happen, the budget will go up further,’ said study co-author Ramanan Laxminarayan from Princeton […]
Read moreRead more Read More - August 6, 2018Researchers detail variation in costs of child vaccination program in Indian states
Accurate and current costs of delivering routine childhood vaccines in India are needed to budget for future growth.
Read moreRead more Read More - July 1, 2018The startups waging war against superbugs.
The Spokesman-Review– July 1, 2018. “‘The science is as good as anywhere else,’ said Ramanan Laxminarayan, a professor at Princeton University and director of the Center for Disease Dynamics, Economics & Policy, based in Washington and New Delhi. ‘On a per-dollar basis, I think the chance of a new antibiotic discovery is as great or higher […]
Read moreRead more Read More - June 26, 2018Drug resistance takes devastating toll on families in India.
National Post– June 26, 2018. “Carbapenem resistance was unheard of as recently as the late 1990s. It has now become widespread in South Asia, says Ramanan Laxminarayan, director of the Center for Disease Dynamics, Economics and Policy and a leading expert.”
Read moreRead more Read More - June 14, 2018Call to widen pneumonia vaccine cover.
The Telegraph India– June 14, 2018. “A study published last month by the Centre for Disease Dynamics, Economics and Policy (CDDEP) had estimated that the introduction of pneumococcal vaccines would cost $240 million (Rs 1,620 crore), more than double the Rs 700 crore India spent on immunization in 2014-15.”
Read moreRead more Read More - June 11, 2018‘Why not take a risk?’ attitude is impeding efforts to stem rise in antibiotic-resistant infections.
Minnpost– June 11, 2018. “The problem is that patients, but more surprisingly clinicians, are not fully recognizing the potential harms from antibiotic use,” said Eili Klein, one of the study’s authors and a mathematical ecologist and epidemiologist at the Center for Disease Dynamics, Economics & Policy (CDDEP), in a released statement. “Despite the fact that approximately 20% […]
Read moreRead more Read More - May 31, 2018Perception that antibiotics are harmless is widespread.
EurekAlert– May 31, 2018. “The problem is that patients, but more surprisingly clinicians, are not fully recognizing the potential harms from antibiotic use”, said Dr. Klein of CDDEP. “Despite the fact that approximately 20% of patients can get some sort of side effect, this does not seem to be as important a factor in decision-making […]
Read moreRead more Read More - May 31, 2018Perception that antibiotics are harmless is widespread
A study of decision-making about the use of antibiotics in medicine has found that the mistaken belief that antibiotics are harmless is widespread, especially among patients.
Read moreRead more Read More
News
One Health Trust’s work and researchers are featured in international media outlets. Find resources to help understand OHT’s work.